The 22nd Congress of the Asian Pacific Society of Respirology will be held at the Sydney International Convention Centre, Sydney, Australia, 23-26 November 2017 www.apsr2017.com Abstracts accepted until 1 June 2017 Early bird registration open 3 September 2017

The Pragmatic Clinical Trial for More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) (TB-PRACTECAL) is a multi-center, open label, multi-arm, randomized, controlled phase II-III trial. TB-PRACTECAL, a Médecins Sans Frontières (MSF) sponsored clinical trial, aims to evaluate short treatment regimens that contain bedaquiline and pretomanid in combination with existing and re-purposed anti-TB drugs for the treatment of biologically confirmed pulmonary MDR- and XDR-TB. The treatment is for six months and the trial’s first patient was randomized and started treatment on January 17, 2017. Additional information on the trial can be found here

A two day symposium showcasing the latest TB research to emerge from Australia will be on from Thursday 1st to Saturday 3rd of June. Dr Gilla Kaplan, the Director of the Tuberculosis programme at the Bill & Melinda Gates Foundation, has kindly agreed to attend the TB-CRE symposium and workshop. For further details, including program click here